Toronto Dominion Bank
OACC

Toronto Dominion Bank’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Toronto Dominion Bank’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.25M Sell
496,650
-178,547
-26% -$1.9M 0.01% 836
2025
Q4 		$7.14M Sell
675,197
-258,803
-28% -$2.74M 0.01% 736
2025
Q3 		$9.82M Buy
934,000
+179,022
+24% +$1.87M 0.02% 618
2025
Q2 		$7.89M Buy
754,978
+268,620
+55% +$2.79M 0.01% 647
2025
Q1 		$4.96M Sell
486,358
-950,542
-66% -$9.54M 0.01% 690
2024
Q4 		$14.4M Buy
+1,436,900
New +$14.3M 0.02% 430

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Toronto Dominion Bank's OACC Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 26% in Q1 2026, selling an estimated $1.9M and leaving 496,650 shares worth $5.25M. The position accounts for 0.01% of the portfolio, ranked #836.

Toronto Dominion Bank first reported a position in OACC in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.4M in Q4 2024. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Toronto Dominion Bank held 496,650 shares of Oaktree Acquisition Corp III Life Sciences worth $5.25M as of Q1 2026.
  • Toronto Dominion Bank sold 178,547 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $1.9M.
  • Oaktree Acquisition Corp III Life Sciences made up 0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #836 holding.
  • Toronto Dominion Bank first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • Toronto Dominion Bank's Oaktree Acquisition Corp III Life Sciences position peaked at $14.4M in Q4 2024.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.